DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Stock buybacks
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DMAARSource: SEC XBRL filings · For reference only · Not investment advice
More DMAAR financial trends
DMAAR RevenueDMAAR Net incomeDMAAR Net marginDMAAR Gross profitDMAAR Gross marginDMAAR Operating incomeDMAAR Operating marginDMAAR Operating cash flowDMAAR Free cash flowDMAAR Capital expendituresDMAAR Return on equityDMAAR Dividends paidDMAAR Total assetsDMAAR Total liabilitiesDMAAR Shareholders’ equityDMAAR overview →